A detailed history of United Capital Financial Advisers, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 3,862 shares of EXAS stock, worth $216,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,862
Holding current value
$216,465
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.43 - $70.83 $163,864 - $273,545
3,862 New
3,862 $262,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $260,523 - $402,316
8,149 New
8,149 $265,000
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $148,805 - $204,558
-1,649 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $5,619 - $8,356
-60 Reduced 3.51%
1,649 $205,000
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $1,049 - $1,395
9 Added 0.53%
1,709 $225,000
Q4 2020

Feb 17, 2021

BUY
$99.61 - $142.12 $169,337 - $241,604
1,700 New
1,700 $225,000
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $517,148 - $723,454
-7,092 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $14,439 - $24,022
-259 Reduced 3.52%
7,092 $617,000
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $333,936 - $920,220
-8,811 Reduced 54.52%
7,351 $426,000
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $37,898 - $48,673
488 Added 3.11%
16,162 $1.5 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $180,740 - $244,980
-2,000 Reduced 11.32%
15,674 $1.42 Million
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $90,494 - $119,338
1,011 Added 6.07%
17,674 $2.09 Million
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $38,861 - $60,505
-627 Reduced 3.63%
16,663 $1.44 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $43,487 - $64,144
776 Added 4.7%
17,290 $1.09 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $797,461 - $1.33 Million
16,514 New
16,514 $1.3 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.